These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 3354621)

  • 41. Effects of AAV-2-mediated aspartoacylase gene transfer in the tremor rat model of Canavan disease.
    McPhee SW; Francis J; Janson CG; Serikawa T; Hyland K; Ong EO; Raghavan SS; Freese A; Leone P
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):112-21. PubMed ID: 15857674
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel splice site mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Rady PL; Penzien JM; Vargas T; Tyring SK; Matalon R
    Eur J Paediatr Neurol; 2000; 4(1):27-30. PubMed ID: 10701101
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absolute configuration of N-acetylaspartate in urine from patients with Canavan disease.
    Bal D; Gryff-Keller A; Gradowska W
    J Inherit Metab Dis; 2005; 28(4):607-9. PubMed ID: 15902566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent advances in Canavan disease.
    Matalon R; Michals-Matalon K
    Adv Pediatr; 1999; 46():493-506. PubMed ID: 10645473
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-acetylaspartic aciduria in a child with a progressive cerebral atrophy.
    Kvittingen EA; Guldal G; Børsting S; Skalpe IO; Stokke O; Jellum E
    Clin Chim Acta; 1986 Aug; 158(3):217-27. PubMed ID: 3769199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Canavan disease (aspartoacylase deficiency)].
    Kobayashi K; Sakuragawa N
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):385-8. PubMed ID: 9590077
    [No Abstract]   [Full Text] [Related]  

  • 47. Spongy degeneration of the brain, Canavan disease: biochemical and molecular findings.
    Matalon RM; Michals-Matalon K
    Front Biosci; 2000 Mar; 5():D307-11. PubMed ID: 10704428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-acetylaspartic acid promotes oxidative stress in cerebral cortex of rats.
    Pederzolli CD; Mescka CP; Scapin F; Rockenbach FJ; Sgaravatti AM; Sgarbi MB; Wyse AT; Wannmacher CM; Wajner M; Dutra-Filho CS
    Int J Dev Neurosci; 2007 Aug; 25(5):317-24. PubMed ID: 17604935
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Canavan disease: from spongy degeneration to molecular analysis.
    Matalon R; Michals K; Kaul R
    J Pediatr; 1995 Oct; 127(4):511-7. PubMed ID: 7562269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Purification and preliminary characterization of brain aspartoacylase.
    Moore RA; Le Coq J; Faehnle CR; Viola RE
    Arch Biochem Biophys; 2003 May; 413(1):1-8. PubMed ID: 12706335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Upregulation of aspartoacylase activity in the duodenum of obesity induced diabetes mouse: implications on diabetic neuropathy.
    Surendran S; Matalon R; Tyring SK
    Biochem Biophys Res Commun; 2006 Jul; 345(3):973-5. PubMed ID: 16707098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Canavan disease: a monogenic trait with complex genomic interaction.
    Surendran S; Michals-Matalon K; Quast MJ; Tyring SK; Wei J; Ezell EL; Matalon R
    Mol Genet Metab; 2003; 80(1-2):74-80. PubMed ID: 14567959
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms.
    Baslow MH; Resnik TR
    J Mol Neurosci; 1997 Oct; 9(2):109-25. PubMed ID: 9407392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of amniotic fluid amino acids in prenatal testing for argininosuccinic aciduria and citrullinaemia.
    Mandell R; Packman S; Laframboise R; Golbus MS; Schmidt K; Workman L; Saudubray JM; Shih VE
    Prenat Diagn; 1996 May; 16(5):419-24. PubMed ID: 8843999
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mental retardation and hypotonia seen in the knock out mouse for Canavan disease is not due to succinate semialdehyde dehydrogenase deficiency.
    Surendran S; Ezell EL; Quast MJ; Wei J; Tyring SK; Michals-Matalon K; Matalon R
    Neurosci Lett; 2004 Mar; 358(1):29-32. PubMed ID: 15016427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutation detection in the aspartoacylase gene in 17 patients with Canavan disease: four new mutations in the non-Jewish population.
    Sistermans EA; de Coo RF; van Beerendonk HM; Poll-The BT; Kleijer WJ; van Oost BA
    Eur J Hum Genet; 2000 Jul; 8(7):557-60. PubMed ID: 10909858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Canavan disease: genomic organization and localization of human ASPA to 17p13-ter and conservation of the ASPA gene during evolution.
    Kaul R; Balamurugan K; Gao GP; Matalon R
    Genomics; 1994 May; 21(2):364-70. PubMed ID: 8088831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Unalp A; Altiok E; Uran N; Oztürk A; Yüksel S
    J Trop Pediatr; 2008 Jun; 54(3):208-10. PubMed ID: 17999961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Leukodystrophy with multiple beaded periventricular cysts: unusual cranial MRI results in Canavan disease.
    Drenckhahn A; Schuelke M; Knierim E
    J Inherit Metab Dis; 2015 Sep; 38(5):983-4. PubMed ID: 25647544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): comparison of enzymatic and metabolite analysis.
    Bennett MJ; Gibson KM; Sherwood WG; Divry P; Rolland MO; Elpeleg ON; Rinaldo P; Jakobs C
    J Inherit Metab Dis; 1993; 16(5):831-6. PubMed ID: 8295397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.